Mifek Jeffrey Gerald purchased $10K of FEMY
Mifek Jeffrey Gerald (Chief Clinical-Medical Affairs) purchased 3,125 shares of FEMASYS INC (FEMY) at $3.20 on 2026-08-07.
How this was made
The 30-second read
Why it matters
The only new fact is the reported open-market purchase by an officer; there is no accompanying company news (earnings, trial results, approvals, contracts, or guidance).
Market read
Traders may note mild sentiment from insider buying, but the disclosure is unlikely to drive a material repricing without additional company catalysts.
What to watch
The filing states no pre-arranged 10b5-1 plan, but it still lacks context on motivation, timing constraints, or whether other insiders are buying/selling.
Background
This is an SEC Form 4 insider transaction disclosure for FEMASYS Inc (FEMY).
Ticker impact
Form 4 shows officer Mifek Jeffrey Gerald bought 3,125 shares of FEMASYS Inc at $3.20 on 2026-08-07, totaling $10,000.
Near-term impact likely limited; any effect would be sentiment-driven rather than fundamental.
The transaction size is modest ($10k) and the filing does not include new operational or financial guidance, clinical, or regulatory developments.
Market effects
No sector read-through is provided beyond a single small insider purchase.
None indicated.
None indicated.
Counterpoint
Insider buys can be routine or tax/portfolio-driven, especially at small dollar amounts, and may not signal improved prospects.
Key entities
- issuerFEMASYS INC
Company whose insider transaction was disclosed on Form 4.
- insiderMifek Jeffrey Gerald
Chief Clinical-Medical Affairs officer who purchased shares.
